Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04GRB
|
||||
Former ID |
DIB001435
|
||||
Drug Name |
THRX-198321
|
||||
Synonyms |
Beta 2 adrenoreceptor agonist/muscarinic receptor antagonist (asthma), Theravance
|
||||
Indication | Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] | Phase 2 | [549872] | ||
Company |
GlaxoSmithKline; Theravance
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1cc(ccc1)c1ccccc1NC(=O)OC1CCN(CC1)CCCCCCCCCNC[C@H](O)c<br />1ccc(c2c1ccc(=O)[nH]2)O
|
||||
Target and Pathway | |||||
Target(s) | Beta-2 adrenergic receptor | Target Info | Modulator | [531285] | |
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | Arf6 trafficking events | ||||
Arf6 signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.